Mr. Ian Campbell reports

NEURAL'S PORTFOLIO COMPANY HANF.COM EXPANDS RETAIL FOOTPRINT TO NORTHERN GERMANY WITH TWO NEW STORES IN BIELEFELD AND HERFORD

Neural Therapeutics Inc., together with its portfolio company CWE European Holdings Inc., operating as Hanf.com, in which it owns 30.75-per-cent interest in, has expanded Hanf.com's retail network into northern Germany with the addition of two new stores in Bielefeld and Herford, both located in the state of North Rhine-Westphalia.

The new Bielefeld store marks Hanf.com's entry into an important regional hub. With a city population of more than 330,000 and an urban area counting close to 600,000 people, Bielefeld is the largest city in the Detmold administrative region. The new location follows Hanf.com's strategic acquisition of an existing CBD retail business in the city. In Herford, a Hanseatic city of approximately 67,000 residents, Hanf.com has similarly acquired an established CBD retail operation, strengthening its presence in the region.

"The addition of two operating stores further expands Hanf.com's national footprint, enhances our brand visibility and supports revenue growth," said Ronnie Jaegermann, chief executive officer of Hanf.com. "We are excited to accelerate growth and strengthen profitability at these locations by bringing our operational efficiencies, industry-leading product offering and customer experience to the vibrant communities of Bielefeld and Herford -- two excellent markets locations with strong growth potential. This was a rare opportunity to acquire two established CBD retail businesses with loyal customer bases and integrate them into the Hanf.com network, which now includes 19 locations across Germany."

About Neural Therapeutics Inc.

Neural Therapeutics is a leader in ethnobotanical drug discovery, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.

On May 26, 2025, Neural entered into a strategic investment and option agreement with CWE European Holdings Inc., a leading CBD hemp retailer in Germany operating under the brand Hanf.com, to acquire up to 100 per cent of CWE through a multistage transaction. The transaction is expected to expand Neural's commercial footprint in Europe while maintaining its core commitment to drug discovery and mental health innovation.

On Aug. 12, 2025, Neural and CWE completed the first part of the transaction, whereby Neural acquired 30.75-per-cent interest in CWE.

We seek Safe Harbor.